In search of double-digit revenue growth: Can big pharma hit its numbers?

Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing

Volumn 4, Issue 1, 2004, Pages 18-26

  McNamara, Linda ^a  

^a Datamonitor Healthcare   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84990338840     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5040139     Document Type: Article

References (6)

1. Leschly, Jan (2002) Speaking at a 2002 IntraLinks Pharmaceutical Breakfast Symposium, ’Partnering % Collaboration = Pipeline Productivity‘, URL: http://www.eyeforpharma.com/index.asp?nli=o&gp&nld=5/14/2002&news=28509.
2. ‘Big Pharma's drought ends’, http://www.forbes.com/2003/05/28/cx_mh_0528pharma.html.
3. Pharmaceutical Research and Manufacturers of America 2002–2003 (PhRMA): Industry Profile; Pharmaceutical Research and Manufacturers of America 2002–2003 (PhRMA): Annual Report.
4. Federal Drug Administration: www.fda.gov/cder/rdmt/NMEapps93-02.htm.
5. URL: http://www.genomeweb.com.
6. Datamonitor (2003) ‘Co-marketing and co-promotional survey 2003’, Datamonitor, September 2003.